Biapenem Inquire about Biapenem

Tecoland supplies Biapenem bulk active pharmaceutical ingredient (API) to the pharmaceutical industry. Our Biapenem is manufactured by cGMP compliant facility. Welcome to contact us for further details including current DMF status for the product and up to date regulatory status of the manufacturing facility. We look forward to assisting you with your research and development projects.

What is Biapenem

Biapenem is a newly developed carbapenem to treat moderate and severe bacterial infections. It has in vitro activity against anaerobes.[1] 1-β-methyl-carbapenem antibiotic. Approved in Japan in 2001.

It is stable to hydrolysis by human renal dihydropeptidase I and showed good clinical and microbiological efficacy in the treatment of patients with intra-abdominal, lower respiratory tract, and complicated urinary tract infections. After intravenous administration it is widely distributed, has linear pharmacokinetics, and is mainly eliminated in the urine with a half-life of approximately 1 h. Biapenem is well tolerated with the most common adverse side effects being skin eruptions/rashes, nausea, and diarrhea.